MARKET

BDSX

BDSX

BIODESIX INC
NASDAQ
1.260
-0.020
-1.56%
Closed 16:00 04/24 EDT
OPEN
1.280
PREV CLOSE
1.280
HIGH
1.280
LOW
1.255
VOLUME
7.10K
TURNOVER
0
52 WEEK HIGH
2.210
52 WEEK LOW
1.030
MARKET CAP
144.06M
P/E (TTM)
-1.9839
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at BDSX last week (0415-0419)?
Weekly Report · 2d ago
Reasons to Hold West Pharmaceutical (WST) in Your Portfolio Now
NASDAQ · 04/17 11:44
Masimo (MASI) Gains Nearly 18% YTD: What's Driving the Rally?
NASDAQ · 04/17 11:43
Weekly Report: what happened at BDSX last week (0408-0412)?
Weekly Report · 04/15 11:13
Biodesix Plans To Present New Data On Liquid Biopsy Technologies At AACR 2024 Annual Meeting
Benzinga · 04/09 21:02
Weekly Report: what happened at BDSX last week (0401-0405)?
Weekly Report · 04/08 11:18
S&P 500 Gains Over 1%; GCT Semiconductor Shares Spike Higher
U.S. Stocks traded higher toward the end of trading on Friday, with the Nasdaq Composite gaining more than 200 points. The Dow traded up 0.89% to 38,941.18 while the NASDAQ rose 1.26%. MediaCo Holding Inc. Shares shot up 190% on Friday after the company reported better-than-expected quarterly results. U.s. Employers added 303,000 nonfarm payrolls in March, easing the unemployment rate to 3.8%. Euro zone European shares closed lower today.
Benzinga · 04/05 18:20
Why Byrna Technologies Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Byrna Technologies shares jumped 7.1% to $14.74 on Friday. The company reported better-than-expected first-quarter revenue and announced a CFO transition. MediaCo Holding Inc. Shares jumped 141.7% in today's mid-day session.
Benzinga · 04/05 17:06
More
About BDSX
Biodesix, Inc. (Biodesix) is a diagnostic solutions and services company. The Company develops diagnostic tests addressing clinical questions by combining multi-omics through the power of artificial intelligence. Biodesix offers over five Medicare-covered tests for patients with lung diseases. The blood based Nodify Lung Nodule Risk Assessment testing strategy, consisting of the Nodify XL2 and the Nodify CDT tests, evaluates the risk of malignancy in incidental pulmonary nodules, enabling physicians to better triage patients to the appropriate course of action. The blood based IQLung strategy for lung cancer patients integrates the GeneStrat targeted ddPCR test, the GeneStrat NGS test and the VeriStrat test to support treatment decisions across all stages of lung cancer. Biodesix also leverages the advanced Diagnostic Cortex artificial intelligence (AI) platform, to collaborate with biotechnology and pharmaceutical companies to solve complex diagnostic challenges in lung disease.

Webull offers Biodesix Inc stock information, including NASDAQ: BDSX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BDSX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BDSX stock methods without spending real money on the virtual paper trading platform.